Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Notes:
Data are from the most recent national surveys available in each country (see [Table GPS-4] for the 15–34 age group).
The age range is from 15 to 18 to 24. Variations in age ranges may to a small extent account for disparities between countries.
Czech Republic: 2002; 18-34 y. n=1002; 18-24 y. n= 389
Denmark: 2000; 16-34 y. n=4141; 16-24 y. n=1754
Germany: 2003; 18-34 y. n=3775; 18-24 y. n=1891
Estonia: 2003; 15-34 y. n=646; 15-24 y. n=329
Greece: 2004; 15-34 y. n=2620; 15-24 y. n=1785
Spain: 2001; 15-34 y. n=6915; 15-24 y. n=3368
France: 2002; 15-34 y. n=724; 15-24 y. n=345
Ireland: 2002/03; 15-34 y. n=n.a.; 15-24 y. n= n.a.
Italy: 2003; 15-34 y. n=5231; 15-24 y. n=2112
Cyprus: 2003; 15-34 y. n=580; 15-24 y. n=420
Latvia: 2003; 15-34 y. n=n.a.; 15-24 y. n=n.a.
Hungary: 2003; 18-34 y. n=2319; 15-24 y. n=943
Netherlands: 2000/01; 15-34 y. n=6687; 15-24 y. n= n.a.
Poland: 2002; 16-34 y. n=n.a.; 16-24 y. n=n.a.
Portugal: 2001; 15-34 y. n=6406; 15-24 y. n=3099
Slovakia: 2002; 18-34 y. n=n.a.; 18-24 y. n=n.a.
Finland: 2002; 15-34 y. n=1240; 15-24 y. n=614
UK (E&W): 2003/04; 16-34 y. n=8590; 16-24 y. n=5429
Norway: 1999; 15-34 y. n=794; 15-24 y. n=n.a.
Source:
Reitox national reports (2004), taken from population surveys, reports or scientific articles. See also [Table GPS-0] in the 2005 statistical bulletin.